As of 2025-07-11, the Net Margin of Kymera Therapeutics Inc (KYMR) is -475.6%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -475.6% |
2023-12-31 | -187% |
2022-12-31 | -330.6% |
2021-12-31 | -137.6% |
2020-12-31 | -134% |
2019-12-31 | -1407.8% |
2018-12-31 | - |
- | |
- | |
- |